TrialActa ophthalmologica2025

Early findings in a randomised controlled trial on crosslinking protocols using isoosmolar and hypoosmolar riboflavin for the treatment of progressive keratoconus.

Ingemar Gustafsson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.